Highest Sampling Of Ayurvedic Medicine In Kerala, Hence Maximum Samples Failed

THIRUVANANTHAPURAM : Kerala has reported the most number of ayurvedic products that are ‘not of standard quality’ (NSQ) in the country. As many as 113 ayurvedic drugs sold in the state were found to be of poor quality. Kerala was followed by Maharashtra with 21 products, said Union Minister for Ayush, Sarbananda Sonowal in reply to a question raised by MP Ramya Haridas in the Lok Sabha on December 16.

He also listed the action taken by drug controllers of different states in a period from 2019 to 2022. Under the Drugs and Cosmetics Act, 1940, Assam’s drug controller found 52 non-compliant samples between 2020 and 2021. It should be noted that 10 states, including Uttar Pradesh, Punjab and Madhya Pradesh, and three Union territories did not report a single case in any category.

Health experts said the list is not comprehensive, but they pointed out that Kerala does have a lot of poor quality drugs and that the drug controller is more active as well.

“The state drug controller is doing a great job by testing ayurvedic drugs to find out those which are not up to standard. It’s a step in the right direction. I hope the state licensing authority will initiate stringent action against those who are violating the drug laws,” said Dr Babu K V, a health activist from Kannur. The controller has actively followed up on drug companies violating regulations, he added.

Dr Raju Thomas, the previous president of the Ayurveda Medical Association of India, said most of the poor quality drugs come from outside the state. “We have a very good regulatory system. But it is a daunting task to check all the drugs that reach the market. There should be an independent regulator with enough manpower for Ayush to make the system more effective,” he added. Drugs controller P M Jayan did not respond to TNIE’s calls seeking a comment.

  • Related Posts

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics Inc, a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, announced the completion of its acquisition of the SimpliDerm hydrated human acellular dermal matrix…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad